Publications by authors named "Harold Harvey"

Claim this Profile
F
First-in-Human Phase 1b Trial of Quinacrine Plus Capecitabine in Patients With Refractory Metastatic Colorectal Cancer.
Arthur Winer, Crystal S Denlinger, Namrata Vijayvergia, Steven J Cohen, Igor Astaturov, Harold A Harvey

Clin Colorectal Cancer· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of the PARP Inhibitor Veliparib with Carboplatin or as a Single Agent in Patients with Germline - or -Associated Metastatic Breast Cancer: California Cancer Consortium Trial NCT01149083.
George Somlo, Paul H Frankel, Banu K Arun, Cynthia X Ma, Agustin A Garcia, Harold A Harvey

Clin Cancer Res· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotherapy for triple-negative breast cancer: Existing challenges and exciting prospects.
Hongyan Jia, Cristina I Truica, Bin Wang, Yanhong Wang, Xingcong Ren, Harold A Harvey

Drug Resist Updat· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognosis and treatment of non-metastatic primary and secondary breast angiosarcoma: a comparative study.
Ming Yin, Wenge Wang, Joseph J Drabick, Harvey A Harold

BMC Cancer· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular profiling of 6,892 colorectal cancer samples suggests different possible treatment options specific to metastatic sites.
Wafik S El-Deiry, Namrata Vijayvergia, Joanne Xiu, Angelique Scicchitano, Bora Lim, Harold A Harvey

Cancer Biol Ther· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary female breast sarcoma: clinicopathological features, treatment and prognosis.
Ming Yin, Heath B Mackley, Joseph J Drabick, Harold A Harvey

Sci Rep· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: A Systematic Review and Two-Step Meta-Analysis.
Ming Yin, Monika Joshi, Richard P Meijer, Michael Glantz, Sheldon Holder, Harold A Harvey

Oncologist· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of topical vaginal androgens in a woman on the testosterone levels of her sexual partner with prostate cancer.
Mhd Y Al-Marrawi, Leah V Cream, Carol A Mallon, Sheldon Holder, Monika Joshi, Harold H Harvey

J Clin Oncol· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endoscopic ultrasound-guided ethanol ablation of a large metastatic carcinoid tumor: success with a note of caution.
Bradley W Mathers, Harold A Harvey, Charles E Dye, Brandy Dougherty-Hamod, Matthew T Moyer

Endosc Int Open· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Personalized dosing via pharmacokinetic monitoring of 5-fluorouracil might reduce toxicity in early- or late-stage colorectal cancer patients treated with infusional 5-fluorouracil-based chemotherapy regimens.
Christina Leah B Kline, Angelique Schiccitano, Junjia Zhu, Cheryl Beachler, Hassan Sheikh, Harold A Harvey

Clin Colorectal Cancer· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting therapy response in live tumor cells isolated with the flexible micro spring array device.
Jean-Nicolas Gallant, Elizabeth M Matthew, Hairong Cheng, Ramdane Harouaka, Nicholas E Lamparella, Harold A Harvey

Cell Cycle· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Update on clinical trials: genetic targets in breast cancer.
Bora Lim, Leah V Cream, Harold A Harvey

Adv Exp Med Biol· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrated regulation of autophagy and apoptosis by EEF2K controls cellular fate and modulates the efficacy of curcumin and velcade against tumor cells.
Yan Cheng, Xingcong Ren, Yi Zhang, Yu Shan, Kathryn J Huber-Keener, Harold Harvey

Autophagy· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identifying circulating tumor stem cells that matter: the key to prognostication and therapeutic targeting.
Bishoy Faltas, Amer Zeidan, Kristi Peters, Avisnata Das, Jamal Joudeh, Harold A Harvey

J Clin Oncol· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of Langerhans cell histiocytosis bone lesions with zoledronic acid: a case series.
Shanthi Sivendran, Harold Harvey, Allan Lipton, Joseph Drabick

Int J Hematol· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gastrointestinal stromal tumor (GIST) recurrence following surgery: review of the clinical utility of imatinib treatment.
Isabelle Deshaies, Jovenel Cherenfant, Niraj J Gusani, Yixing Jiang, Harold A Harvey

Ther Clin Risk Manag· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II trial of gemcitabine, irinotecan, and celecoxib in patients with advanced pancreatic cancer.
Allan Lipton, Cynthia Campbell-Baird, Lois Witters, Harold Harvey, Suhail Ali

J Clin Gastroenterol· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Opioid growth factor improves clinical benefit and survival in patients with advanced pancreatic cancer.
Jill P Smith, Sandra I Bingaman, David T Mauger, Harold H Harvey, Laurence M Demers

Open Access J Clin Trials· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I trial of zoledronic acid + imatinib mesylate (Gleevec) in patients with bone metastases.
Allan Lipton, Cynthia Campbell-Baird, Harold Harvey, Christian Kim, Laurence Demers

Am J Clin Oncol· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biology of bone metastases: causes and consequences.
Harold A Harvey, Leah von Reyn Cream

Clin Breast Cancer· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toremifene: an evaluation of its safety profile.
Harold A Harvey, Morihiko Kimura, Alajos Hajba

Breast· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypercalcemia and gallium nitrate.
Harold A Harvey, Salah M Almokadem

J Support Oncol· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum HER-2/neu conversion to positive at the time of disease progression in patients with breast carcinoma on hormone therapy.
Allan Lipton, Kim Leitzel, Suhail M Ali, Laurence Demers, Harold A Harvey

Cancer· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gemcitabine/Irinotecan/celecoxib in pancreatic cancer.
Allan Lipton, Harold Harvey, Lois Witters, Samuel Kerr, Kathryn Legore

Oncology (Williston Park)· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimizing bisphosphonate therapy in patients with breast cancer on endocrine therapy.
Harold A Harvey

Semin Oncol· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis